| Randomized Trial of Health Events Costs in Diabetic Blacks (NCT00022750) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2000-10-01 |
| A Study of the Efficacy and Safety of Topiramate in the Treatment fo Obese, Type 2 Diabetic Patients Treated With Metformin (NCT00231660) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2000-10-01 |
| Pharmacist Assisted Medication Program Enhancing the Regulation of Diabetes (NCT00541606) | Lahey Clinic | 2000-09-01 |
| AVANDIA With Glyburide In African American And Hispanic Patients With Type 2 Diabetes Not Controlled by Glyburide Alone (NCT00333723) | GlaxoSmithKline | 2000-07-28 |
| NEW DAY: Nutrition, Exercise, Weight Loss, Diabetes And You (NCT00007800) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2000-05-01 |
| Defective Atypical Protein Kinase C (PKC) Activation in Diabetes and Metabolic Syndrome (NCT00690755) | VA Office of Research and Development | 2000-05-01 |
| A Study of the Safety and Effectiveness of Topiramate on Insulin Sensitivity in Overweight or Obese Patients With Type 2 Diabetes (NCT00236626) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2000-04-01 |
| Rosiglitazone on Microalbuminuria in Type 2 Diabetics (NCT00500955) | GlaxoSmithKline | 2000-04-01 |
| Comparison of Biphasic Human Insulin 30 With Biphasic Insulin Aspart in Subjects With Diabetes (NCT01520818) | Novo Nordisk A/S | 2000-03-01 |
| Diabetes Study With Rosiglitazone Monotherapy Versus Metformin Or Glyburide/Glibenclamide (NCT00279045) | GlaxoSmithKline | 2000-01-03 |
| Effect of Insulin Glargine in Insulin Naïve Subjects With Type 2 Diabetes on Oral Hypoglycemic Agent(s) (NCT00653341) | Sanofi | 2000-01-01 |
| Evaluating "Health at Every Size"(HAES) as an Alternative Obesity Treatment Model (NCT00074633) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2000-01-01 |
| Diabetes Aerobic and Resistance Exercise (DARE) Study (NCT00195884) | Ottawa Hospital Research Institute | 1999-09-01 |
| Six Month Clinical Trial Assessing Efficacy And Safety Of Inhaled Insulin In Type 2 Diabetes (NCT00424411) | Pfizer | 1999-09-01 |
| Regional Fatty Acid Metabolism in Humans (NCT00068887) | Mayo Clinic | 1999-09-01 |
| Effect of Liraglutide on Pulsatile Insulin Secretion in Subjects With Type 2 Diabetes (NCT01507311) | Novo Nordisk A/S | 1999-09-01 |
| Action to Control Cardiovascular Risk in Diabetes (ACCORD) (NCT00000620) | National Heart, Lung, and Blood Institute (NHLBI) | 1999-09-01 |
| Safety and Tolerability of Liraglutide in Healthy Volunteers and Subjects With Type 2 Diabetes (NCT01507285) | Novo Nordisk A/S | 1999-08-01 |
| Effect on Glycemic Control of Inhaled Insulin Alone or Added to Dual Oral Therapy After Failure of Dual Oral Therapy. (NCT00370565) | Pfizer | 1999-06-01 |
| Comparison of Two Biphasic Insulin Aspart Treatments in Subjects With Type 2 Diabetes (NCT01520753) | Novo Nordisk A/S | 1999-03-01 |
| Multi-Ethnic Study of Atherosclerosis (MESA) (NCT00005487) | National Heart, Lung, and Blood Institute (NHLBI) | 1999-01-01 |
| Efficacy and Safety of Biphasic Insulin Aspart 30 in Type 1 or Type 2 Diabetes (NCT01467323) | Novo Nordisk A/S | 1998-04-01 |
| Computer-assisted Diabetes Self-management Interventions (NCT00006163) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 1997-09-01 |
| DETAIL Study: Diabetes Exposed to Telmisartan and Enalapril (NCT00274118) | Boehringer Ingelheim | 1997-07-01 |
| Screening for Undiagnosed Type 2 Diabetes in New Classes of Subjects at High Risk (NCT00520962) | IRCCS San Raffaele | 1997-06-01 |
| Localisation of Potential Insulin Deposits in Normal Weight and Obese Diabetics Using 6 mm and 12 mm Long Needles (NCT00871416) | Novo Nordisk A/S | 1997-04-09 |
| Pharmacokinetics, Pharmacodynamics and Safety of Biphasic Insulin Aspart 30 in Type 2 Diabetes (NCT01697618) | Novo Nordisk A/S | 1997-04-01 |
| A Study of the Efficacy of Prolonged-Release Melatonin Versus Placebo in Diabetic Patients Suffering From Insomnia (NCT00869128) | Neurim Pharmaceuticals Ltd. | 1995-11-01 |
| Lifestyle Interventions to Reduce Diabetes Risk (NCT00006162) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 1994-10-01 |
| Cross-Sectional and Longitudinal Studies of "Pre-Diabetes" in the Pima Indians (NCT00340132) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 1983-01-01 |
| Prospective Studies of the Natural History of Diabetes Mellitus and Its Complications in the Gila River Indian Community (NCT00339482) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 1976-09-03 |
| Study Protocol for Rosiglitazone Versus Gliclazide in Diabetics With Angina (NCT00225342) | University of Glasgow | |
| The Effect of Metformin Treatment on Thyroid Hormone Metabolism in Euthyroid Patients With Type 2 Diabetes Mellitus (NCT00463502) | Haydarpasa Numune State Hospital | |
| Native Hawaiian Diabetes Intervention Program (NCT00006165) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | |
| Glucagon Like Peptides Receptors Expression in the Stomach of Diabetes Type 2 (NCT00473733) | Assaf-Harofeh Medical Center | |
| Insulin Resistance and Insulin Secretion (NCT00073294) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | |
| The Effects of Breakfast Size on Hormonal Profile in Adults With Type 2 Diabetes Mellitus (NCT01178723) | Wolfson Medical Center | |
| Diagnosis of Insulin Resistance: 13C-Glucose Breath Test Vs HOMA Index. (NCT00264940) | Tel-Aviv Sourasky Medical Center | |
| Improving Medication Adherence in Comorbid Conditions (NCT00072891) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | |